Chronic Non Bacterial Prostatitis: a Trial of TRUS Guided Injection of Betamethason

Chronic Non Bacterial Prostatitis Clinical Trial

Official title:

Managment of Refractory Cases of Chronic Non Bacterial Prostatitis by TRUS Guided Injection of Betamethason

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04210739
• Other study ID #: chronic prostatitis
• Status: Not yet recruiting
• Phase: Early Phase 1
• Start date: July 2020
• Est. completion date: December 2021

Study information

• Verified date: December 2019
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

TRUS guided injection of long acting corticosteroids in chronic non bacterial prostatitis patients who failed to response to medical treamtment

Description:

chronic non bacterial prostatitis is usually due to congestion combined with severe inflammatory process of the prostate, it is usually a recurrent bothersome problem, so patients who fail to response to classic medical treatment are expected to benefit from a strong anti inflammatory injection like betamethasone, which has strong anti inflammatory plus anti oedematous properties so limitation of this inflammatory process across the prostate is expected to relieve the patients symptoms

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 20
• Est. completion date: December 2021
• Est. primary completion date: July 2021
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 20 Years to 45 Years

Eligibility

Inclusion Criteria:

• chronic non bacterial prostatitis who failed medical treatment

Exclusion Criteria:

• chronic bacterial prostatitis patients

Related Conditions & MeSH terms

• Chronic Non Bacterial Prostatitis
• Prostatitis

Intervention

Drug:
• Betamethason Sodium Phosphate
Injection of betamethasone in chronic non bacterial prostatitis patients using Trans rectal Ultrasound

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Comparing IPSS before and after injection.	Questionnaire comparing IPSS (international prostatic symptom score) before and after injection	evaluation over 3 months after injection